Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2840228rdf:typepubmed:Citationlld:pubmed
pubmed-article:2840228lifeskim:mentionsumls-concept:C0010825lld:lifeskim
pubmed-article:2840228lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2840228lifeskim:mentionsumls-concept:C0009498lld:lifeskim
pubmed-article:2840228lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:2840228lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:2840228lifeskim:mentionsumls-concept:C0151449lld:lifeskim
pubmed-article:2840228pubmed:issue1lld:pubmed
pubmed-article:2840228pubmed:dateCreated1988-9-6lld:pubmed
pubmed-article:2840228pubmed:abstractTextAntibodies to cytomegalovirus (CMV) were examined in sera from 21 consecutive patients with primary Sjögren's syndrome (SS) and 19 consecutive patients with secondary SS, using a complement fixation (CF) test and an antibody capture enzyme-linked immunosorbent assay (ELISA). Sera from 15 CMV-negative subjects, 15 CMV-positive subjects, 3 patients with primary CMV infection and 3 patients with recurrent CMV infection served as controls. The prevalence of CMV antibodies in the patients with primary and secondary SS was found similar to the prevalence known to occur in the normal adult population. Unrelated to clinical parameters, 5 patients with primary SS (24%) had high levels of CF antibodies against CMV. Ig class antibodies to CMV were not elevated in these 5 patients. Preferential production of CF antibodies to CMV may be a pathogenetic factor in some patients with primary SS.lld:pubmed
pubmed-article:2840228pubmed:languageenglld:pubmed
pubmed-article:2840228pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840228pubmed:citationSubsetIMlld:pubmed
pubmed-article:2840228pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2840228pubmed:statusMEDLINElld:pubmed
pubmed-article:2840228pubmed:issn0392-856Xlld:pubmed
pubmed-article:2840228pubmed:authorpubmed-author:AndersenH KHKlld:pubmed
pubmed-article:2840228pubmed:authorpubmed-author:OxholmPPlld:pubmed
pubmed-article:2840228pubmed:authorpubmed-author:ThornJ JJJlld:pubmed
pubmed-article:2840228pubmed:issnTypePrintlld:pubmed
pubmed-article:2840228pubmed:volume6lld:pubmed
pubmed-article:2840228pubmed:ownerNLMlld:pubmed
pubmed-article:2840228pubmed:authorsCompleteYlld:pubmed
pubmed-article:2840228pubmed:pagination71-4lld:pubmed
pubmed-article:2840228pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:meshHeadingpubmed-meshheading:2840228-...lld:pubmed
pubmed-article:2840228pubmed:articleTitleHigh levels of complement fixing antibodies against cytomegalovirus in patients with primary Sjögren's syndrome.lld:pubmed
pubmed-article:2840228pubmed:affiliationDepartment of Oral Medicine, Rigshospitalet, Copenhagen, Denmark.lld:pubmed
pubmed-article:2840228pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2840228lld:pubmed